Profile data is unavailable for this security.
About the company
Chlitina Holding Limited is a holding company. The Company and its subsidiaries are engaged in the manufacture, distribution, and business operations of beauty products under the brand of Chlitina, Company-operated salon business and aesthetic medicine clinic. Its subsidiaries include Chlitina Marketing Limited, K&S Biomedical Ltd., Hong Kong Chlitina International Limited, Hua Pao Sdn. Bhd., Chlitina (China) Trade Limited, and others. Chlitina Marketing Limited is engaged in the investing and trading of skincare products. K&S Biomedical Ltd is engaged in the trading of skincare products and daily necessities. Hong Kong Chlitina International Limited is involved in investing and trading of skincare products. Hua Pao Sdn. Bhd. is a dealer of skincare products. Chlitina (China) Trade Limited is a dealer of skincare products and supplementary healthcare products.
- Revenue in TWD (TTM)3.80bn
- Net income in TWD495.57m
- Incorporated2012
- Employees--
- LocationChlitina Holding LtdCricket Square,, Hutchins Drive,,PO Box 2681TAIPEI KY1-1111Cayman IslandsCYM
- Phone+1 345 227238666
- Fax+886 287580369
- Websitehttps://www.chlitinaholding.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Luo Lih Fen Holding Co Ltd | 1.09bn | 113.03m | 2.06bn | -- | 18.22 | 1.26 | 12.32 | 1.89 | 2.38 | 2.38 | 23.04 | 34.44 | 0.489 | 4.64 | 143.52 | -- | 4.75 | 3.77 | 6.16 | 4.57 | 64.24 | 60.94 | 9.71 | 8.43 | 1.71 | -- | 0.0317 | 94.02 | 16.01 | -4.87 | -8.50 | -30.50 | -18.90 | -22.16 |
| Kuangli Bio Tech Holdings Co Ltd | 387.37m | -193.36m | 2.59bn | -- | -- | 4.24 | -- | 6.69 | -2.29 | -2.29 | 4.47 | 6.27 | 0.3654 | 6.23 | 6.01 | -- | -18.24 | -7.41 | -24.93 | -10.93 | 18.27 | 20.59 | -49.92 | -23.32 | 1.39 | -10.31 | 0.4136 | -- | 29.97 | -2.16 | -65.89 | -- | 41.96 | -- |
| Maywufa Co Ltd | 1.55bn | 174.62m | 2.92bn | 282.00 | 16.74 | 1.40 | 12.74 | 1.89 | 1.31 | 1.31 | 11.60 | 15.68 | 0.4994 | 1.98 | 5.89 | -- | 5.64 | 6.22 | 6.51 | 7.24 | 63.65 | 65.27 | 11.30 | 13.15 | 2.14 | 41.42 | 0.2356 | 88.98 | 14.23 | 6.18 | 2.44 | 11.48 | 118.16 | 14.87 |
| KNH Enterprise Co Ltd | 2.74bn | -369.74m | 3.28bn | 1.04k | -- | 1.45 | -- | 1.20 | -1.89 | -1.89 | 14.04 | 11.58 | 0.4194 | 3.70 | 3.33 | -- | -5.66 | 2.90 | -7.37 | 3.83 | 6.17 | 16.80 | -13.48 | 5.49 | 1.74 | -9.79 | 0.5787 | 76.70 | -0.034 | -6.26 | -155.94 | -- | 2.45 | 0.00 |
| Farcent Enterprise Co Ltd | 2.44bn | 280.16m | 3.36bn | 350.00 | 12.01 | 1.72 | 9.54 | 1.38 | 4.43 | 4.43 | 38.61 | 30.84 | 0.9567 | 4.84 | 6.22 | -- | 12.23 | 11.43 | 15.95 | 15.79 | 50.33 | 46.00 | 12.78 | 10.55 | 3.00 | -- | 0.0312 | 73.68 | -3.48 | -5.73 | 8.25 | -5.94 | -23.66 | -4.42 |
| Maxigen Biotech Inc | 792.49m | 234.07m | 3.97bn | 96.00 | 17.02 | 2.70 | 15.07 | 5.01 | 2.60 | 2.60 | 8.81 | 16.43 | 0.4891 | 3.11 | 7.31 | -- | 14.45 | 9.87 | 16.62 | 11.15 | 69.33 | 61.07 | 29.54 | 22.47 | 3.84 | -- | 0.00 | 40.53 | 9.41 | 8.52 | 14.68 | 25.90 | 6.00 | 4.21 |
| Chlitina Holding Ltd | 3.80bn | 495.57m | 9.07bn | -- | 19.07 | 1.88 | 11.50 | 2.39 | 5.77 | 5.77 | 43.17 | 58.50 | 0.4255 | 1.52 | 718.54 | -- | 5.54 | 10.00 | 8.19 | 14.60 | 82.17 | 83.39 | 13.03 | 20.51 | 1.50 | 11.41 | 0.3834 | 85.25 | -10.32 | -4.57 | -54.27 | -19.88 | 20.61 | -5.06 |
| Yuen Foong Yu Consumer Products Co Ltd | 10.84bn | 757.73m | 10.20bn | 1.59k | 13.48 | 1.88 | 8.30 | 0.9414 | 2.83 | 2.83 | 40.55 | 20.34 | 1.11 | 5.81 | 8.53 | -- | 7.77 | 11.97 | 10.90 | 16.86 | 23.98 | 25.79 | 7.02 | 9.71 | 1.13 | -- | 0.3054 | 78.49 | 6.16 | 0.6511 | -23.07 | 9.84 | 58.46 | -- |
| Holder | Shares | % Held |
|---|---|---|
| Fidelity Management & Research Co. LLCas of 31 Dec 2025 | 3.42m | 4.15% |
| The Vanguard Group, Inc.as of 04 Feb 2026 | 1.83m | 2.22% |
| Dimensional Fund Advisors LPas of 05 Feb 2026 | 997.59k | 1.21% |
| Dimensional Fund Advisors Ltd.as of 30 Nov 2025 | 64.14k | 0.08% |
| American Century Investment Management, Inc.as of 05 Feb 2026 | 62.15k | 0.08% |
| Vanguard Fiduciary Trust Co.as of 30 Nov 2025 | 55.96k | 0.07% |
| SSgA Funds Management, Inc.as of 05 Feb 2026 | 53.14k | 0.06% |
| DFA Australia Ltd.as of 31 Dec 2025 | 17.21k | 0.02% |
| Vanguard Asset Management Ltd.as of 31 Dec 2025 | 6.46k | 0.01% |
| CI Investments, Inc.as of 30 Jun 2025 | 1.79k | 0.00% |
